These studies provide important information about patterns of splicing abnormalities in cancer tissues or the impact of AS alterations in some cancer patients who harbour somatic mutations in specific splicing factors, including U2AF1 and SF3B1 (Kahles et al, 2018; Zhang et al, 2022). Here, SF3B1 is linked to cancer.